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patients in the study was 5.8 (standard deviation, SD=3.5) years in the control group and 5.7 (SD=3.2) years in the intervention group. Seventy-six per cent of patients in each group were male, and 63% of the control group were white versus 67% of the intervention group. The authors did not comment on how representative the study sample was of a more general population.
Study design
This was a single-centre study utilising a cross-sectional, retrospective cohort study. The method by which the intervention group was randomly selected was not stated. The length of follow-up appears to have been one month following the surgical intervention. There appears to have been no loss to follow-up. The study was not blinded.
Analysis of effectiveness
All of the patients included in the study were accounted for in the analysis. The primary health outcomes were wound infection rate, anaesthesia and procedure times, times in the post-anaesthesia care unit (PACU), and PACU step-down and readmissions. The groups were shown to have been comparable in terms of their age, gender and white origin.
Effectiveness results
In the control group, the mean times were 52 (SD=13) minutes for anaesthesia, 24 (SD=11) minutes for the procedure, 43 (SD=17) minutes in the PACU, and 54 (SD=19) minutes for PACU step-down. The overall time was 149 (SD=30) minutes.
In the intervention group, the mean times were 49 (SD=10) minutes for anaesthesia, 21 (SD=7) minutes for the procedure, 40 (SD=12) minutes in the PACU, and 49 (SD=21) minutes for PACU step-down. The overall time was 138 (SD=25) minutes.
The difference in overall time between the control and study groups was not statistically significant, (p=0.056).
There were no statistically significant differences in wound infection rate or readmissions between the treatment groups.
Clinical conclusions
The authors concluded that this study showed that the CP maintained the quality of care associated with standard practice.
Measure of benefits used in the economic analysis
No summary measure of health benefit was used in the economic analysis. Hence, a cost-consequences analysis was performed. The study also showed no difference in effectiveness between the two groups. Therefore, the results could also be viewed as a cost-minimisation analysis.
Direct costs
The resource quantities and the costs were not reported separately. The study recorded the direct hospital costs. These included supplies and laboratory testing, associated surgery, and hotel costs. Professional fees and the cost of follow-up visits were excluded from the analysis. The source of the cost data and the estimation of the price data were not described, and the date to which they related was not available. Discounting was not relevant as the costs were incurred during less than one year. The study reported the average costs.
Statistical analysis of costs
The mean costs and SDs, and p-values for the difference in mean cost between the groups were provided. The authors stated that analysis of variance and chi-squared tests were used to assess differences between the groups, although the
